These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 34522420)

  • 1. Carbamazepine-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Overlap Treated Successfully with Oral Cyclosporin: Case report and literature review.
    Al Rajaibi R; Al Rumhi T; Al Abri AM
    Sultan Qaboos Univ Med J; 2021 Aug; 21(3):491-494. PubMed ID: 34522420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of cyclosporine in Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Gilbert M; Scherrer LA
    Dermatol Ther; 2019 Jan; 32(1):e12758. PubMed ID: 30285308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Lerch M; Mainetti C; Terziroli Beretta-Piccoli B; Harr T
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):147-176. PubMed ID: 29188475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures.
    Schneider JA; Cohen PR
    Adv Ther; 2017 Jun; 34(6):1235-1244. PubMed ID: 28439852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness, safety and tolerability of cyclosporine versus supportive treatment in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A record-based study.
    Mohanty S; Das A; Ghosh A; Sil A; Gharami RC; Bandyopadhyay D; Das NK
    Indian J Dermatol Venereol Leprol; 2017; 83(3):312-316. PubMed ID: 28366923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stevens-johnson Syndrome and Toxic Epidermal Necrolysis: An Overview of Diagnosis, Therapy Options and Prognosis of Patients.
    Garg VK; Buttar HS; Bhat SA; Ainur N; Priya T; Kashyap D; Tuli HS
    Recent Adv Inflamm Allergy Drug Discov; 2023; 17(2):110-120. PubMed ID: 37605396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Hasegawa A; Abe R
    F1000Res; 2020; 9():. PubMed ID: 32595945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis overlap in a Filipino with positive HLA-B75 serotype.
    Capule F; Tragulpiankit P; Mahasirimongkol S; Wichukchinda N; Jittikoon J; Alentajan-Aleta LT; James Barit JV; Casanova-Gutierrez J; Cabral-Lim L; Baltazar Reyes JP; Roa F; San Gabriel KF; Silao CL
    BMJ Case Rep; 2018 Jul; 2018():. PubMed ID: 30018035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful Use of Cyclosporin A for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Three Children.
    St John J; Ratushny V; Liu KJ; Bach DQ; Badri O; Gracey LE; Ho AW; Raff AB; Sugai DY; Schalock P; Kroshinsky D
    Pediatr Dermatol; 2017 Sep; 34(5):540-546. PubMed ID: 28884910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of toxic epidermal necrolysis by a multidisciplinary team. A review of literature and treatment results.
    Papp A; Sikora S; Evans M; Song D; Kirchhof M; Miliszewski M; Dutz J
    Burns; 2018 Jun; 44(4):807-815. PubMed ID: 29627131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Case Report and Literature Review.
    Meledathu S; Gordon M; Thornton M; Ashinoff R
    J Drugs Dermatol; 2023 Nov; 22(11):e24-e28. PubMed ID: 37943271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Review of Diagnosis and Management.
    Frantz R; Huang S; Are A; Motaparthi K
    Medicina (Kaunas); 2021 Aug; 57(9):. PubMed ID: 34577817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with anticonvulsants in a Japanese population: Matched case-control and cohort studies.
    Fukasawa T; Takahashi H; Takahashi K; Tanemura N; Amagai M; Urushihara H
    Allergol Int; 2021 Jul; 70(3):335-342. PubMed ID: 33618992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agreement Among Different Scales for Causality Assessment in Drug-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Sivagourounadin K; Rajendran P; Selvarajan S; Ganesapandian M
    Curr Drug Saf; 2022; 17(1):40-46. PubMed ID: 34126908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric SJS/TEN Subdued by a Combination of Dexamethasone, Cyclosporine, and Etanercept.
    Coulombe J; Belzile E; Duhamel A; Rault P; Buteau C; DeBruycker JJ; Bussières JF
    J Cutan Med Surg; 2019; 23(5):547-550. PubMed ID: 31478770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective analysis of mortality risk and immunosuppressive therapy for Stevens-Johnson Syndrome and toxic epidermal necrolysis syndrome using the TriNetX research network.
    Ozhathil DK; Powell CM; Corley CV; Golovko G; Song J; El Ayadi A; Wolf SE; Kahn SA
    Burns; 2024 Feb; 50(1):75-86. PubMed ID: 37734977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxic epidermal necrolysis and Stevens-Johnson syndrome/toxic epidermal necrolysis overlap in pediatric patients with a focus on newer antiepileptic drugs: A 25-year retrospective study at a single tertiary care center.
    Gleghorn KL; Voigt C; Kelly B
    Pediatr Dermatol; 2021 Jul; 38(4):812-818. PubMed ID: 34060145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stevens-Johnson syndrome-toxic epidermal necrolysis (SJS-TEN) overlap associated with carbamazepine use.
    Suresh Kumar PN; Thomas B; Kumar K; Kumar S
    Indian J Psychiatry; 2005 Apr; 47(2):121-3. PubMed ID: 20711297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stevens Johnson syndrome-Toxic Epidermal Necrolysis Overlap induced by sulfasalazine treatment: a case report.
    Zizi N; Elmrahi A; Dikhaye S; Fihmi N; Alami Z
    Tunis Med; 2015 Jul; 93(7):413-5. PubMed ID: 26757493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulins, cyclosporine, and best supportive care in epidermal necrolysis: Diverse effects on systemic inflammation.
    Schmidt V; Lalevée S; Traidl S; Ameri M; Ziadlou R; Ingen-Housz-Oro S; Barau C; de Prost N; Nägeli M; Mitamura Y; Meier-Schiesser B; Navarini AA; French LE; Contassot E; Brüggen MC
    Allergy; 2023 May; 78(5):1280-1291. PubMed ID: 36463488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.